To better understand the potential for ibogaine and to better address the public health challenges caused by things like opioid use disorder, an FDA clinical drug trial is needed for ibogaine. I'm about to sign a law that will lead to an FDA approved drug development clinical trial that will seek approval of ibogaine as a medication for the treatment of opioid use disorder and other behavioral health conditions, especially those suffered by our veterans. Texas will invest $50 million to support this research and these funds can be matched by grants and private investments. I'm proud to send it into law. (01:56–02:15)
CLAIM
Asserts that a new law will initiate an FDA trial for ibogaine for treating opioid use disorder and other conditions.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
